KCM
BSX icon

Kennedy Capital Management’s Boston Scientific BSX Stock Holding History

Kennedy Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.91M Buy
138,518
+76,212
+122% +$4.14M 0.1% 296
2026
Q1 		$3.91M Buy
62,306
+24,863
+66% +$1.99M 0.08% 336
2025
Q4 		$3.57M Sell
37,443
-815
-2% -$79.9K 0.08% 349
2025
Q3 		$3.74M Sell
38,258
-44,620
-54% -$4.62M 0.08% 342
2025
Q2 		$8.9M Sell
82,878
-9,270
-10% -$938K 0.21% 163
2025
Q1 		$9.3M Sell
92,148
-7,367
-7% -$742K 0.22% 158
2024
Q4 		$8.89M Buy
99,515
+20,635
+26% +$1.82M 0.2% 158
2024
Q3 		$6.61M Buy
78,880
+3,591
+5% +$283K 0.15% 247
2024
Q2 		$5.8M Buy
75,289
+31,187
+71% +$2.28M 0.12% 275
2024
Q1 		$3.02M Buy
+44,102
New +$2.84M 0.06% 445
2016
Q1 		– Sell
-15,205
Closed -$280K – 732
2015
Q4 		$280K Hold
15,205
– – 0.01% 720
2015
Q3 		$250K Hold
15,205
– – 0.01% 707
2015
Q2 		$269K Hold
15,205
– – ﹤0.01% 717
2015
Q1 		$270K Hold
15,205
– – ﹤0.01% 707
2014
Q4 		$201K Hold
15,205
– – ﹤0.01% 732
2014
Q3 		$180K Hold
15,205
– – ﹤0.01% 759
2014
Q2 		$194K Hold
15,205
– – ﹤0.01% 733
2014
Q1 		$206K Hold
15,205
– – ﹤0.01% 728
2013
Q4 		$183K Sell
15,205
-524
-3% -$6.19K ﹤0.01% 734
2013
Q3 		$185K Hold
15,729
– – ﹤0.01% 742
2013
Q2 		$146K Buy
+15,729
New +$133K ﹤0.01% 732

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kennedy Capital Management's BSX Position: Q2 2026 in Review

Kennedy Capital Management increased its Boston Scientific (BSX) stake by 122% in Q2 2026, buying an estimated $4.14M and bringing the position to 138,518 shares worth $5.91M. The position accounts for 0.1% of the portfolio, ranked #296.

Kennedy Capital Management first reported a position in BSX in Q2 2013 and has held it in 21 quarters since. The position peaked at $9.3M in Q1 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Kennedy Capital Management held 138,518 shares of Boston Scientific worth $5.91M as of Q2 2026.
  • Kennedy Capital Management bought 76,212 Boston Scientific shares in Q2 2026, an estimated $4.14M.
  • Boston Scientific made up 0.1% of Kennedy Capital Management's portfolio in Q2 2026, its #296 holding.
  • Kennedy Capital Management first reported a position in Boston Scientific in Q2 2013 and has held it in 21 quarters since.
  • Kennedy Capital Management's Boston Scientific position peaked at $9.3M in Q1 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.